| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,055,981,000 as of 7/29 |
| Market
Cap: |
52.42(B) |
| Last
Volume: |
3,685,357 |
Avg
Vol: |
5,469,851 |
| 52
Week Range: |
$35.89 - $50.01 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 357 |
| Guru Rank Value : 2.1 |
| Guru Occurances : 4 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
Company Profile Medtronic is a medical technology company. Co. develops, manufactures, and markets medical devices. Co.'s primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose, and throat conditions. Co. operates under two operating segments that manufacture and sell device-based medical therapies: cardiac and vascular group, which is composed of its Cardiac Rhythm Disease Management and CardioVascular businesses; and restorative therapies group, which is composed of its Spinal, Neuromodulation, Diabetes, and Surgical Technologies businesses.
|
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
41,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,580,300 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
62,740 |
| Total Sell Value |
$0 |
$0 |
$0 |
$2,415,531 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2013-02-17 |
2012-11-16 |
2012-05-18 |
2011-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leavitt Michael O |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
4,465 |
|
- |
|
| Schuler Jack W |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
536,088 |
|
- |
|
| Pozen Robert C |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
45,558 |
|
- |
|
| Lenehan James T |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
30,446 |
|
- |
|
| Jackson Shirley A |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
24,253 |
|
- |
|
| Anderson Richard H |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
31,481 |
|
- |
|
| Oleary Denise M |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
25,262 |
|
- |
|
| Dzau Victor J |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
15,520 |
|
- |
|
| Powell Kendall J |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989 |
16,625 |
|
- |
|
| Reddy Preetha |
|
– • – |
2013-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,791 |
1,791 |
|
- |
|
| Szyman Catherine M |
SrVP & Pres Diabetes |
• – – |
2012-11-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,244 |
|
10% |
|
| Martha Geoffrey |
Sr VP, Strategy & Bus Dev |
• – – |
2012-10-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,639 |
|
6% |
|
| Ellis Gary Lee |
SrVP & Chief Financial Officer |
• – – |
2012-10-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,200 |
166,802 |
|
- |
|
| Dallas H James |
SrVP Quality, Operations, IT |
• – – |
2012-08-03 |
4 |
D |
$39.81 |
$97,375 |
D/D |
(2,446) |
114,200 |
|
- |
|
| Ellis Gary Lee |
SrVP & Chief Financial Officer |
• – – |
2012-08-03 |
4 |
D |
$39.81 |
$194,711 |
D/D |
(4,891) |
168,002 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• – – |
2012-08-03 |
4 |
D |
$39.81 |
$116,842 |
D/D |
(2,935) |
99,737 |
|
- |
|
| Oconnell Christopher J |
EVP & GroupPres Restora Therap |
• – – |
2012-08-03 |
4 |
D |
$39.81 |
$97,614 |
D/D |
(2,452) |
115,661 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• – – |
2012-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,913 |
77,680 |
|
- |
|
| Dallas H James |
SrVP Quality, Operations, IT |
• – – |
2012-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,307 |
116,645 |
|
- |
|
| Ellis Gary Lee |
SrVP & Chief Financial Officer |
• – – |
2012-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,614 |
172,892 |
|
- |
|
| Findlay D Cameron |
SrVP Gneral Counsel & Corp Sec |
• – – |
2012-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
15,460 |
72,298 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2012-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
72,585 |
570,741 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• – – |
2012-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,307 |
102,672 |
|
- |
|
| Oconnell Christopher J |
EVP & GroupPres Restora Therap |
• – – |
2012-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,913 |
118,113 |
|
- |
|
| Stockdale Caroline |
Sr VP Human Resources |
• – – |
2012-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,307 |
43,946 |
|
- |
|
850 Records found
|
|
Page 1 of 34 |
|
|
0.37 (0.74%) 
